{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:26:42Z","timestamp":1778797602210,"version":"3.51.4"},"reference-count":67,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Aim: The aim of this study was to determine the prevalence of mental disorders in a group of patients with multiple sclerosis (MS) during outpatient treatment. Additionally, an attempt was made to assess the influence of parameters related to patients and their clinical status on the prevalence of mental disorders. Materials and Methods: This study was conducted between 2017 and 2018 in a group of 103 patients with MS who underwent treatment at the Outpatient Clinic of Neurology at the Clinical Hospital No. 1 in Zabrze, Poland. Sociodemographic data were collected, and the course of the underlying disease and comorbidities underwent assessment. The Mini International Neuropsychiatric Interview (MINI) and psychiatric examination were used to assess the occurrence of mental disorders. Results: In this study, female subjects accounted for 67.96% of patients (mean age: 43 years). Of all patients, 67% of subjects were clinically diagnosed with mental disorders during their lifetime. The results of the MINI Questionnaire showed that 33% of MS patients had a history of a major depressive episode, while 8.7% of patients met the criteria for a depressive episode. The same number of patients were treated for recurrent depressive disorders. Generalized anxiety disorder was diagnosed in 10.7% of patients, agoraphobia in 8.7% and panic disorder in 7.8%. Most patients (94.2%) had a low risk of suicide, according to the MINI Questionnaire. This study did not show a significant influence of age, sex, duration of MS symptoms or severity of symptoms as expressed by the Expanded Disability Status Score (EDSS) on the prevalence of mental disorders (p = 0.05). However, a significantly higher median EDSS score was found in patients with a history of mental disorders (p = 0.03). Additionally, a significant negative correlation was found between having a family and a psychiatric diagnosis (p = 0.01). A statistically significant negative correlation was found between the level of education and the suicide risk as assessed by the MINI Questionnaire (p = 0.03). Conclusions: This study showed a high prevalence of mental disorders in patients with MS, of which depressive episodes and anxiety disorders were the most commonly reported. There may exist a relationship between the degree of disability of MS patients and a higher prevalence of mental disorders. Patients with MS who do not have a family may be more susceptible to mental disorders. In turn, patients with a lower level of education may show a higher risk of suicide. This suggests the need for psychological and psychiatric support for patients with MS, with particular consideration given to those who are alone, those with more severe disability and patients with a lower level of education.<\/jats:p>","DOI":"10.3390\/medicina60030376","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T04:31:23Z","timestamp":1708662683000},"page":"376","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk Factors for Psychiatric Disorders in Patients with Multiple Sclerosis\u2014A Single-Center Study in the Polish Population"],"prefix":"10.3390","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1610-036X","authenticated-orcid":false,"given":"Hubert","family":"Mado","sequence":"first","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4438-2376","authenticated-orcid":false,"given":"Micha\u0142","family":"B\u0142achut","sequence":"additional","affiliation":[{"name":"Chair and Clinical Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2160-4589","authenticated-orcid":false,"given":"Anna","family":"Szczegielniak","sequence":"additional","affiliation":[{"name":"Psychiatric Ward, Multi-Specialist District Hospital, 42-612 Tarnowskie G\u00f3ry, Poland"},{"name":"Department of Psychiatric Rehabilitation, Department of Psychiatry and Psychotherapy, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"\u015awierzy","sequence":"additional","affiliation":[{"name":"Psychiatric Ward, Multi-Specialist District Hospital, 42-612 Tarnowskie G\u00f3ry, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Zaj\u0105c","sequence":"additional","affiliation":[{"name":"Psychiatric Ward, Multi-Specialist District Hospital, 42-612 Tarnowskie G\u00f3ry, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Kubicka-B\u0105czyk","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Gorczyca","sequence":"additional","affiliation":[{"name":"Chair and Clinical Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6894-9891","authenticated-orcid":false,"given":"Monika","family":"Adamczyk-Sowa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/WNL.0000000000000768","article-title":"Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity","volume":"83","author":"Browne","year":"2014","journal-title":"Neurology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"A387","DOI":"10.1016\/j.autrev.2009.11.010","article-title":"Multiple sclerosis: Geoepidemiology, genetics and the environment","volume":"9","author":"Milo","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/jnnp-2016-314013","article-title":"Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis","volume":"87","author":"Tao","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.09.005","article-title":"Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis","volume":"93","author":"Dutta","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/brain\/awl007","article-title":"Natural history of multiple sclerosis: A unifying concept","volume":"129","author":"Confavreux","year":"2006","journal-title":"Brain"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1191\/1352458503ms856oa","article-title":"On receiving the diagnosis of multiple sclerosis: Managing the transition","volume":"9","author":"Johnson","year":"2003","journal-title":"Mult. Scler."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/487159","article-title":"Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study","volume":"2015","author":"Alsaadi","year":"2015","journal-title":"Mult. Scler. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jnnp.25.4.315","article-title":"The distribution of plaques in the cerebrum in multiple sclerosis","volume":"25","author":"Brownell","year":"1962","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/070674370404900302","article-title":"The Neuropsychiatry of Multiple Sclerosis","volume":"49","author":"Feinstein","year":"2004","journal-title":"Can. J. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s004150170184","article-title":"Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects","volume":"248","author":"Zorzon","year":"2001","journal-title":"J. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"II73","DOI":"10.1007\/s00415-007-2017-2","article-title":"Neuropsychiatric syndromes associated with multiple sclerosis","volume":"254","author":"Feinstein","year":"2007","journal-title":"J. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1352458514564487","article-title":"The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1440-1819.2005.01446.x","article-title":"Severe impulsiveness as the primary manifestation of multiple sclerosis in a young female","volume":"59","year":"2005","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1176\/appi.ajp.161.2.226","article-title":"Pure Neuropsychiatric Presentation of Multiple Sclerosis","volume":"161","author":"Taber","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1176\/jnp.11.1.5","article-title":"Neuropsychiatric Presentation of Multiple Sclerosis","volume":"11","author":"Hurley","year":"1999","journal-title":"J. Neuropsychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jnnp.s1-7.25.1","article-title":"Original Papers: The affective symptomatology of disseminated sclerosis: A study of 100 cases","volume":"7","author":"Cottrell","year":"1926","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1176\/ajp.140.11.1498","article-title":"Depressive episodes in patients with multiple sclerosis","volume":"140","author":"Schiffer","year":"1983","journal-title":"Am. J. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.msard.2015.10.004","article-title":"Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis","volume":"5","author":"Fiest","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1037\/a0035919","article-title":"Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis","volume":"59","author":"Amtmann","year":"2014","journal-title":"Rehabil. Psychol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s00415-016-8146-8","article-title":"Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial","volume":"263","author":"Schippling","year":"2016","journal-title":"J. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archneur.1992.00530360098025","article-title":"Suicide and Patients With Neurologic Diseases","volume":"49","author":"Stenager","year":"1992","journal-title":"Arch. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1176\/jnp.2010.22.1.63","article-title":"Mental Disorders in Mexican Patients With Multiple Sclerosis","volume":"22","author":"Flores","year":"2010","journal-title":"J. Neuropsychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.msard.2016.10.003","article-title":"A systematic review of anxiety amongst people with Multiple Sclerosis","volume":"10","author":"Butler","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.comppsych.2015.08.001","article-title":"Psychiatric disorders in patients with multiple sclerosis","volume":"63","author":"Barreiros","year":"2015","journal-title":"Compr. Psychiatry"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4088\/PCC.v10n0408","article-title":"Neuropsychiatric Manifestations of Multiple Sclerosis","volume":"10","author":"Politte","year":"2008","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00415-005-0963-0","article-title":"Unrecognised symptoms of depression in a community\u2013based population with multiple sclerosis","volume":"253","author":"McGuigan","year":"2005","journal-title":"J. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/135245850100700511","article-title":"Quality of life in multiple sclerosis: The impact of depression, fatigue and disability","volume":"7","author":"Amato","year":"2001","journal-title":"Mult. Scler. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jns.2013.08.021","article-title":"Improving the quality of mental health care in Multiple Sclerosis","volume":"335","author":"Minden","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.msard.2015.02.003","article-title":"On the origin of EDSS","volume":"4","author":"Kurtzke","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_33","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"ref_34","first-page":"393","article-title":"The MINI-International Neuropsychiatric Interview. A brief structured diagnostic psychiatric interview for DSM-IV en ICD-10 psychiatric disorders","volume":"49","year":"2007","journal-title":"Tijdschr. Psychiatr."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Pettersson, A., Modin, S., Wahlstr\u00f6m, R., Hammarberg, S.A.W., and Krakau, I. (2018). The Mini-International Neuropsychiatric Interview is useful and well accepted as part of the clinical assessment for depression and anxiety in primary care: A mixed-methods study. BMC Fam. Pract., 19.","DOI":"10.1186\/s12875-017-0674-5"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7224\/1537-2073.2016-110","article-title":"Diagnoses of Depression and Anxiety Versus Current Symptoms and Quality of Life in Multiple Sclerosis","volume":"20","author":"Marrie","year":"2018","journal-title":"Int. J. MS Care"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/jnnp.2006.090654","article-title":"A population-based study of depressive symptoms in multiple sclerosis in Stockholm county: Association with functioning and sense of coherence","volume":"78","author":"Gottberg","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Karimi, S., Andayeshgar, B., and Khatony, A. (2020). Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: A cross-sectional study. BMC Psychiatry, 20.","DOI":"10.1186\/s12888-020-02579-z"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10072-005-0468-8","article-title":"Psychiatric disorders and depression in multiple sclerosis outpatients: Impact of disability and interferon beta therapy","volume":"26","author":"Galeazzi","year":"2005","journal-title":"Neurol. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/09540261.2017.1322555","article-title":"Depression in multiple sclerosis","volume":"29","author":"Patten","year":"2017","journal-title":"Int. Rev. Psychiatry"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jns.2016.11.067","article-title":"Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis","volume":"372","author":"Boeschoten","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.msard.2017.12.007","article-title":"The validity and reliability of screening measures for de-pression and anxiety disorders in multiple sclerosis","volume":"20","author":"Marrie","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jpsychores.2015.08.007","article-title":"A comparison of multiple patient reported outcome measures in identifying major depressive disorder in people with multiple sclerosis","volume":"79","author":"Amtmann","year":"2015","journal-title":"J. Psychosom. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0165-0327(00)00298-6","article-title":"Depression associated with multiple sclerosis: Looking beyond diagnosis to symptom expression","volume":"66","author":"Feinstein","year":"2001","journal-title":"J. Affect. Disord."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1352458506071161","article-title":"Anxiety disorders and their clinical correlates in multiple sclerosis patients","volume":"13","author":"Korostil","year":"2007","journal-title":"Mult. Scler. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1212\/01.WNL.0000110316.12086.0C","article-title":"Structural brain abnormalities in multiple sclerosis patients with major depression","volume":"62","author":"Feinstein","year":"2004","journal-title":"Neurology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.socscimed.2004.06.012","article-title":"Chronic disease and mental disorder","volume":"60","author":"Verhaak","year":"2005","journal-title":"Soc. Sci. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: When the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.msard.2018.09.008","article-title":"Adverse psychiatric effects of disease-modifying therapies in multiple Sclerosis: A systematic review","volume":"26","author":"Gasim","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/0022146510395592","article-title":"Mechanisms Linking Social Ties and Support to Physical and Mental Health","volume":"52","author":"Thoits","year":"2011","journal-title":"J. Health Soc. Behav."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.genhosppsych.2012.10.011","article-title":"Psychiatric symptoms in patients with multiple sclerosis","volume":"35","author":"Terzi","year":"2013","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1177\/1352458506070935","article-title":"Prediction of anxiety and distress following diagnosis of multiple sclerosis: A two-year longitudinal study","volume":"12","author":"Janssens","year":"2006","journal-title":"Mult. Scler. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2005.08.019","article-title":"Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies","volume":"245","author":"Amato","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"ref_54","first-page":"2605","article-title":"Predicting cognitive decline in multiple sclerosis: A 5-year follow-up study","volume":"141","author":"Eijlers","year":"2018","journal-title":"Brain"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.59.5.674","article-title":"An examination of suicidal intent in patients with multiple sclerosis","volume":"59","author":"Feinstein","year":"2002","journal-title":"Neurology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/pcn.12089","article-title":"Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: Comparison with schizophrenia","volume":"68","author":"Altamura","year":"2013","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_57","unstructured":"Mental Health ATLAS 2017 (2024, January 15). World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789241514019."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.12740\/PP\/30811","article-title":"The prevalence of common mental disorders in the population of adult Poles by sex and age structure\u2014An EZOP Poland study","volume":"49","author":"Kiejna","year":"2015","journal-title":"Psychiatr. Polska"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1586\/ern.10.99","article-title":"Multiple sclerosis-associated fatigue","volume":"10","author":"Krupp","year":"2010","journal-title":"Expert. Rev. Neurother."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Flensner, G., Landtblom, A.-M., S\u00f6derhamn, O., and Ek, A.-C. (2013). Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: A cross-sectional study. BMC Public Health, 13.","DOI":"10.1186\/1471-2458-13-224"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/01376517-200806000-00009","article-title":"Managing chronic sorrow: Experiences of patients with multiple sclerosis","volume":"40","author":"Isaksson","year":"2008","journal-title":"J. Neurosci. Nurs."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/1352458514549400","article-title":"Changing definitions of euphoria in multiple sclerosis: A short report","volume":"21","author":"Duncan","year":"2014","journal-title":"Mult. Scler. J."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Johansson, S., Gottberg, K., Kierkegaard, M., and Ytterberg, C. (2016). Variations in and predictors of the occurrence of depressive symptoms and mood symptoms in multiple sclerosis: A longitudinal two-year study. BMC Neurol., 16.","DOI":"10.1186\/s12883-016-0551-1"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e2216","DOI":"10.1212\/WNL.0000000000008617","article-title":"Disability worsening among persons with multiple sclerosis and depression","volume":"93","author":"Binzer","year":"2019","journal-title":"Neurology"},{"key":"ref_65","first-page":"65","article-title":"Psychopharmacology of patients with multiple sclerosis in Greece during the period 2017\u20132019","volume":"33","author":"Bakirtzis","year":"2022","journal-title":"Psychiatriki"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"102888","DOI":"10.1016\/j.msard.2021.102888","article-title":"Serotoninergic system targeting in multiple sclerosis: The prospective for pathogenetic therapy","volume":"51","author":"Melnikov","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Runeson, B., Odeberg, J., Pettersson, A., Edbom, T., Adamsson, I.J., and Waern, M. (2017). Instruments for the assessment of suicide risk: A systematic review evaluating the certainty of the evidence. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180292"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/3\/376\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:03:39Z","timestamp":1760105019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/3\/376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["medicina60030376"],"URL":"https:\/\/doi.org\/10.3390\/medicina60030376","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]}}}